Back
Merck KGaA 10K Form
Sell
24
MKGAF
Merck KGaA
Last Price:
150.75
Seasonality Move:
-1.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MKGAF News And Ratings
See the #1 stock for the next 7 days that we like better than MKGAF
MKGAF Financial Statistics
Sales & Book Value
| Annual Sales: | $22.73B |
|---|---|
| Cash Flow: | $1.01B |
| Price / Cash Flow: | 27.9 |
| Annual Sales: | $72.76 |
| Price / Book: | 2.07 |
Profitability
| EPS (TTM): | 6.73410 |
|---|---|
| Net Income (TTM): | $2.93B |
| Gross Margin: | $13.42B |
| Return on Equity: | 9.62% |
| Return on Assets: | 5.44% |
Merck KGaA Earnings Forecast
Key Merck KGaA Financial Ratios
- The Gross Profit Margin over the past 22 years for MKGAF is 59.03%.
- The Selling, General & Administrative Expenses for MKGAF have been equal to 25.28% of Gross Profit Margin.
- The Research & Development expenses have been 11.65% of Revenue.
- The Interest Expense is 11.37% of Operating Income.
- The Net Earning history of MKGAF is 13.45% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 12 years.
Merck KGaA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | MKGAF |
| Website: | emdgroup.com |
Debt
| Debt-to-Equity Ratio: | 0.4 |
|---|---|
| Current Ratio: | 1.33 |
| Quick Ratio: | 0.8 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.46 |
|---|---|
| Forward P/E Ratio: | 0 |
MKGAF Technical Analysis vs Fundamental Analysis
Sell
24
Merck KGaA (MKGAF)
is a Sell
Is Merck KGaA a Buy or a Sell?
-
Merck KGaA stock is rated a Sell
The current Merck KGaA [MKGAF] share price is $150.75. The Score for MKGAF is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.